The FDA has approved Caplyta as adjunctive therapy with antidepressants to treat major depressive disorder in adults, ...

Scientists have identified a significant link between low levels of choline and the prevalence of anxiety disorders, ...

Deep TMS™ becomes first and only TMS device cleared in treatment of patients aged 15 to 86 suffering from depressionBURLINGTON, Mass. and JERUSALEM, Israel, Nov. 13, 2025 (GLOBE NEWSWIRE) -- BrainsWay ...

Mess does not necessarily equal chaos. Chaos happens when your mess exceeds your ability to live inside it. If something is making functioning hard for you, it’s a real barrier.

New findings reported in JAMA Network Open from a longitudinal cohort study utilizing electronic health records (EHRs) show that individuals with a prior serious mental illness (SMI), including ...

New data reveals a rising trend in generalized anxiety disorder (GAD) prevalence among U.S. adults, emphasizing the need for improved diagnosis and treatment. It was found that more than one in ten ...

Entered into an Agreement to be acquired by QOL MedicalNet product sales for the third quarter of 2025 reached $4.3 million; ...

New brain imaging technology helps veterans with PTSD and trauma find healing through objective evidence of invisible ...

SINGAPORE – For father-of-four Esmond Wee, 44, living with attention deficit hyperactivity disorder (ADHD) means buying five pairs of earplugs – because he keeps misplacing them – to ease sensory ...

The FDA has issued a CRL to Biohaven regarding the NDA for troriluzole for the treatment of adults with spinocerebellar ataxia.

Attention deficit hyperactivity disorder, or ADHD, is a long-term neurodevelopmental disorder usually found and diagnosed in ...